Global Peptide Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Peptide Therapeutics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 Injection
  • 1.2.3 Oral
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Cancer
  • 1.3.3 Metabolic Disorders
  • 1.3.4 Central Nervous System
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Peptide Therapeutics Market Size Estimates and Forecasts
• 2.2 Peptide Therapeutics Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Peptide Therapeutics Revenue by Region: 2020-2025
  • 2.2.2 Global Peptide Therapeutics Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Peptide Therapeutics Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Peptide Therapeutics Revenue by Type (2020-2031)
  • 3.1.2 Global Peptide Therapeutics Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Peptide Therapeutics Revenue by Application (2020-2031)
  • 3.2.2 Global Peptide Therapeutics Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 Injection of Peptide Therapeutics Revenue Market Share by Application
  • 3.3.2 Oral of Peptide Therapeutics Revenue Market Share by Application
  • 3.3.3 Other of Peptide Therapeutics Revenue Market Share by Application

4 Global Peptide Therapeutics by Company

• 4.1 Global Peptide Therapeutics Revenue by Company (2020-2025)
• 4.2 Global Peptide Therapeutics Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Peptide Therapeutics Companies around the World: Ranking by Revenue
  • 4.3.2 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Peptide Therapeutics Companies Headquarters & Product Type
  • 4.4.1 Global Peptide Therapeutics Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Peptide Therapeutics Market
  • 4.4.3 Global Peptide Therapeutics Companies Product & Service
  • 4.4.4 Injection Revenue Market Share of Peptide Therapeutics by Company
  • 4.4.5 Oral Revenue Market Share of Peptide Therapeutics by Company
  • 4.4.6 Other Revenue Market Share of Peptide Therapeutics by Company
• 4.5 Global Peptide Therapeutics Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 Sanofi
  • 5.1.1 Sanofi Corporation Information
  • 5.1.2 Sanofi Description, Business Overview
  • 5.1.3 Sanofi Peptide Therapeutics Products Offered
  • 5.1.4 Sanofi Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.1.5 Sanofi Peptide Therapeutics Revenue by Product in 2024
  • 5.1.6 Sanofi Peptide Therapeutics Revenue by Application in 2024
  • 5.1.7 Sanofi Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.1.8 Sanofi Recent Developments
• 5.2 Teva
  • 5.2.1 Teva Corporation Information
  • 5.2.2 Teva Description, Business Overview
  • 5.2.3 Teva Peptide Therapeutics Products Offered
  • 5.2.4 Teva Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.2.5 Teva Peptide Therapeutics Revenue by Product in 2024
  • 5.2.6 Teva Peptide Therapeutics Revenue by Application in 2024
  • 5.2.7 Teva Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.2.8 Teva Recent Developments
• 5.3 Novo Nordisk
  • 5.3.1 Novo Nordisk Corporation Information
  • 5.3.2 Novo Nordisk Description, Business Overview
  • 5.3.3 Novo Nordisk Peptide Therapeutics Products Offered
  • 5.3.4 Novo Nordisk Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.3.5 Novo Nordisk Peptide Therapeutics Revenue by Product in 2024
  • 5.3.6 Novo Nordisk Peptide Therapeutics Revenue by Application in 2024
  • 5.3.7 Novo Nordisk Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.3.8 Novo Nordisk Recent Developments
• 5.4 Takeda
  • 5.4.1 Takeda Corporation Information
  • 5.4.2 Takeda Description, Business Overview
  • 5.4.3 Takeda Peptide Therapeutics Products Offered
  • 5.4.4 Takeda Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.4.5 Takeda Peptide Therapeutics Revenue by Product in 2024
  • 5.4.6 Takeda Peptide Therapeutics Revenue by Application in 2024
  • 5.4.7 Takeda Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.4.8 Takeda Recent Developments
• 5.5 Eli Lilly
  • 5.5.1 Eli Lilly Corporation Information
  • 5.5.2 Eli Lilly Description, Business Overview
  • 5.5.3 Eli Lilly Peptide Therapeutics Products Offered
  • 5.5.4 Eli Lilly Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.5.5 Eli Lilly Peptide Therapeutics Revenue by Product in 2024
  • 5.5.6 Eli Lilly Peptide Therapeutics Revenue by Application in 2024
  • 5.5.7 Eli Lilly Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.5.8 Eli Lilly Recent Developments
• 5.6 AstraZeneca
  • 5.6.1 AstraZeneca Corporation Information
  • 5.6.2 AstraZeneca Description, Business Overview
  • 5.6.3 AstraZeneca Peptide Therapeutics Products Offered
  • 5.6.4 AstraZeneca Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.6.5 AstraZeneca Peptide Therapeutics Revenue by Product in 2024
  • 5.6.6 AstraZeneca Peptide Therapeutics Revenue by Application in 2024
  • 5.6.7 AstraZeneca Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.6.8 AstraZeneca Recent Developments
• 5.7 Novartis
  • 5.7.1 Novartis Corporation Information
  • 5.7.2 Novartis Description, Business Overview
  • 5.7.3 Novartis Peptide Therapeutics Products Offered
  • 5.7.4 Novartis Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.7.5 Novartis Peptide Therapeutics Revenue by Product in 2024
  • 5.7.6 Novartis Peptide Therapeutics Revenue by Application in 2024
  • 5.7.7 Novartis Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.7.8 Novartis Recent Developments
• 5.8 AbbVie
  • 5.8.1 AbbVie Corporation Information
  • 5.8.2 AbbVie Description, Business Overview
  • 5.8.3 AbbVie Peptide Therapeutics Products Offered
  • 5.8.4 AbbVie Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.8.5 AbbVie Peptide Therapeutics Revenue by Product in 2024
  • 5.8.6 AbbVie Peptide Therapeutics Revenue by Application in 2024
  • 5.8.7 AbbVie Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.8.8 AbbVie Recent Developments
• 5.9 Ipsen
  • 5.9.1 Ipsen Corporation Information
  • 5.9.2 Ipsen Description, Business Overview
  • 5.9.3 Ipsen Peptide Therapeutics Products Offered
  • 5.9.4 Ipsen Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.9.5 Ipsen Peptide Therapeutics Revenue by Product in 2024
  • 5.9.6 Ipsen Peptide Therapeutics Revenue by Application in 2024
  • 5.9.7 Ipsen Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.9.8 Ipsen Recent Developments
• 5.10 Ferring
  • 5.10.1 Ferring Corporation Information
  • 5.10.2 Ferring Description, Business Overview
  • 5.10.3 Ferring Peptide Therapeutics Products Offered
  • 5.10.4 Ferring Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.10.5 Ferring Peptide Therapeutics Revenue by Product in 2024
  • 5.10.6 Ferring Peptide Therapeutics Revenue by Application in 2024
  • 5.10.7 Ferring Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.10.8 Ferring Recent Developments
• 5.11 Merck
  • 5.11.1 Merck Corporation Information
  • 5.11.2 Merck Description, Business Overview
  • 5.11.3 Merck Peptide Therapeutics Products Offered
  • 5.11.4 Merck Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.11.5 Merck Peptide Therapeutics Revenue by Product in 2024
  • 5.11.6 Merck Peptide Therapeutics Revenue by Application in 2024
  • 5.11.7 Merck Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.11.8 Merck Recent Developments
• 5.12 The Medicines
  • 5.12.1 The Medicines Corporation Information
  • 5.12.2 The Medicines Description, Business Overview
  • 5.12.3 The Medicines Peptide Therapeutics Products Offered
  • 5.12.4 The Medicines Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.12.5 The Medicines Peptide Therapeutics Revenue by Product in 2024
  • 5.12.6 The Medicines Peptide Therapeutics Revenue by Application in 2024
  • 5.12.7 The Medicines Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.12.8 The Medicines Recent Developments
• 5.13 J & J
  • 5.13.1 J & J Corporation Information
  • 5.13.2 J & J Description, Business Overview
  • 5.13.3 J & J Peptide Therapeutics Products Offered
  • 5.13.4 J & J Peptide Therapeutics Revenue and Gross Margin (2020-2025)
  • 5.13.5 J & J Peptide Therapeutics Revenue by Product in 2024
  • 5.13.6 J & J Peptide Therapeutics Revenue by Application in 2024
  • 5.13.7 J & J Peptide Therapeutics Revenue by Geographic Area in 2024
  • 5.13.8 J & J Recent Developments

6 North America

• 6.1 North America Peptide Therapeutics Market Size YoY Growth 2020-2031
• 6.2 North America Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
• 6.3 North America Peptide Therapeutics Revenue by Type (2020-2025)
• 6.4 North America Peptide Therapeutics Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Peptide Therapeutics Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Peptide Therapeutics Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Peptide Therapeutics Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Peptide Therapeutics Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Peptide Therapeutics Market Size YoY Growth 2020-2031
• 8.2 Europe Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Peptide Therapeutics Revenue by Type (2020-2025)
• 8.4 Europe Peptide Therapeutics Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Peptide Therapeutics Market Size YoY Growth 2020-2031
• 9.2 Latin America Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Peptide Therapeutics Revenue by Type (2020-2025)
• 9.4 Latin America Peptide Therapeutics Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Peptide Therapeutics Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Peptide Therapeutics Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Peptide Therapeutics Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Peptide Therapeutics Supply Chain Analysis
• 11.2 Peptide Therapeutics Key Raw Materials and Upstream Suppliers
• 11.3 Peptide Therapeutics Clients Analysis
• 11.4 Peptide Therapeutics Sales Channel and Sales Model Analysis
  • 11.4.1 Peptide Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Peptide Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Peptide Therapeutics Distributors

12 Peptide Therapeutics Market Dynamics

• 12.1 Peptide Therapeutics Industry Trends
• 12.2 Peptide Therapeutics Market Drivers
• 12.3 Peptide Therapeutics Market Challenges
• 12.4 Peptide Therapeutics Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Peptide Therapeutics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Peptide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Peptide Therapeutics Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Peptide Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Peptide Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Peptide Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Peptide Therapeutics Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)

Table 11. Peptide Therapeutics Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Peptide Therapeutics Players by Revenue (US$ Million) in 2024

Table 13. Global Peptide Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Peptide Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)

Table 15. Global Peptide Therapeutics Companies Headquarters

Table 16. Date of International Companies Enter into Peptide Therapeutics Market

Table 17. Global Peptide Therapeutics Companies Product & Service

Table 18. Global Peptide Therapeutics Mergers & Acquisitions, Expansion Plans

Table 19. Sanofi Corporation Information

Table 20. Sanofi Description and Business Overview

Table 21. Sanofi Peptide Therapeutics Product

Table 22. Sanofi Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Sanofi Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 24. Sanofi Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 25. Sanofi Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 26. Sanofi Recent Developments

Table 27. Teva Corporation Information

Table 28. Teva Description and Business Overview

Table 29. Teva Peptide Therapeutics Product

Table 30. Teva Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Teva Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 32. Teva Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 33. Teva Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 34. Teva Recent Developments

Table 35. Novo Nordisk Corporation Information

Table 36. Novo Nordisk Description and Business Overview

Table 37. Novo Nordisk Peptide Therapeutics Product

Table 38. Novo Nordisk Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 40. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 41. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 42. Novo Nordisk Recent Developments

Table 43. Takeda Corporation Information

Table 44. Takeda Description and Business Overview

Table 45. Takeda Peptide Therapeutics Product

Table 46. Takeda Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Takeda Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 48. Takeda Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 49. Takeda Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 50. Takeda Recent Developments

Table 51. Eli Lilly Corporation Information

Table 52. Eli Lilly Description and Business Overview

Table 53. Eli Lilly Peptide Therapeutics Product

Table 54. Eli Lilly Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Eli Lilly Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 56. Eli Lilly Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 57. Eli Lilly Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 58. Eli Lilly Recent Developments

Table 59. AstraZeneca Corporation Information

Table 60. AstraZeneca Description and Business Overview

Table 61. AstraZeneca Peptide Therapeutics Product

Table 62. AstraZeneca Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. AstraZeneca Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 64. AstraZeneca Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 65. AstraZeneca Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 66. AstraZeneca Recent Developments

Table 67. Novartis Corporation Information

Table 68. Novartis Description and Business Overview

Table 69. Novartis Peptide Therapeutics Product

Table 70. Novartis Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Novartis Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 72. Novartis Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 73. Novartis Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 74. Novartis Recent Developments

Table 75. AbbVie Corporation Information

Table 76. AbbVie Description and Business Overview

Table 77. AbbVie Peptide Therapeutics Product

Table 78. AbbVie Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. AbbVie Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 80. AbbVie Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 81. AbbVie Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 82. AbbVie Recent Developments

Table 83. Ipsen Corporation Information

Table 84. Ipsen Description and Business Overview

Table 85. Ipsen Peptide Therapeutics Product

Table 86. Ipsen Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. Ipsen Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 88. Ipsen Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 89. Ipsen Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 90. Ipsen Recent Developments

Table 91. Ferring Corporation Information

Table 92. Ferring Description and Business Overview

Table 93. Ferring Peptide Therapeutics Product

Table 94. Ferring Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Ferring Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 96. Ferring Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 97. Ferring Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 98. Ferring Recent Developments

Table 99. Merck Corporation Information

Table 100. Merck Description and Business Overview

Table 101. Merck Peptide Therapeutics Product

Table 102. Merck Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Merck Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 104. Merck Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 105. Merck Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 106. Merck Recent Developments

Table 107. The Medicines Corporation Information

Table 108. The Medicines Description and Business Overview

Table 109. The Medicines Peptide Therapeutics Product

Table 110. The Medicines Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 111. The Medicines Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 112. The Medicines Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 113. The Medicines Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 114. The Medicines Recent Developments

Table 115. J & J Corporation Information

Table 116. J & J Description and Business Overview

Table 117. J & J Peptide Therapeutics Product

Table 118. J & J Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 119. J & J Revenue Proportion of Peptide Therapeutics by Product in 2024

Table 120. J & J Revenue Proportion of Peptide Therapeutics by Application in 2024

Table 121. J & J Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024

Table 122. J & J Recent Developments

Table 123. North America Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 124. North America Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 125. North America Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)

Table 126. North America Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)

Table 127. Asia-Pacific Peptide Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 128. Asia-Pacific Peptide Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 129. Asia-Pacific Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)

Table 130. Asia-Pacific Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)

Table 131. Europe Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 132. Europe Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 133. Europe Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)

Table 134. Europe Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)

Table 135. Latin America Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 136. Latin America Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 137. Latin America Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)

Table 138. Latin America Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)

Table 139. Middle East and Africa Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 140. Middle East and Africa Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 141. Middle East and Africa Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)

Table 142. Middle East and Africa Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)

Table 143. Peptide Therapeutics Key Raw Materials, Industry Status and Trend

Table 144. Peptide Therapeutics Key Raw Materials and Upstream Suppliers

Table 145. Peptide Therapeutics Clients Status and Trend

Table 146. Peptide Therapeutics Typical Clients

Table 147. Peptide Therapeutics Distributors

Table 148. Peptide Therapeutics Market Trends

Table 149. Peptide Therapeutics Market Drivers

Table 150. Peptide Therapeutics Market Challenges

Table 151. Peptide Therapeutics Market Restraints

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

List of Figures

Figure 1. Peptide Therapeutics Product Picture

Figure 2. Global Peptide Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Peptide Therapeutics Revenue Market Share by Type in 2024 & 2031

Figure 4. Injection Product Picture

Figure 5. Oral Product Picture

Figure 6. Other Product Picture

Figure 7. Global Peptide Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Peptide Therapeutics Revenue Market Share by Application in 2024 & 2031

Figure 9. Cancer

Figure 10. Metabolic Disorders

Figure 11. Central Nervous System

Figure 12. Other

Figure 13. Peptide Therapeutics Report Years Considered

Figure 14. Global Peptide Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Peptide Therapeutics Market Size (2020-2031) & (US$ Million)

Figure 16. Global Peptide Therapeutics Market Size Market Share by Region: 2024 Versus 2031

Figure 17. Global Peptide Therapeutics Revenue Market Share by Region (2020-2031)

Figure 18. Global Peptide Therapeutics Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Global Peptide Therapeutics Revenue Market Share Forecast by Application (2020-2031)

Figure 20. Injection of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031

Figure 21. Oral of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031

Figure 22. Other of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031

Figure 23. Peptide Therapeutics Revenue Share by Company (2024)

Figure 24. Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Injection Revenue Proportion by Company in 2024

Figure 26. Oral Revenue Proportion by Company in 2024

Figure 27. Other Revenue Proportion by Company in 2024

Figure 28. North America Peptide Therapeutics Revenue 2020-2031 (US$ Million)

Figure 29. North America Peptide Therapeutics Revenue Market Share by Type (2020-2025)

Figure 30. North America Peptide Therapeutics Revenue Market Share by Application (2020-2025)

Figure 31. Asia-Pacific Peptide Therapeutics Revenue 2020-2031 (US$ Million)

Figure 32. Asia-Pacific Peptide Therapeutics Revenue Market Share by Region (2020-2031)

Figure 33. Asia-Pacific Peptide Therapeutics Revenue Market Share by Type (2020-2025)

Figure 34. Asia-Pacific Peptide Therapeutics Revenue Market Share by Application (2020-2025)

Figure 35. Europe Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 36. Europe Peptide Therapeutics Revenue Market Share by Country (2020-2031)

Figure 37. Europe Peptide Therapeutics Revenue Market Share by Type (2020-2025)

Figure 38. Europe Peptide Therapeutics Revenue Market Share by Application (2020-2025)

Figure 39. Latin America Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Latin America Peptide Therapeutics Revenue Market Share by Country (2020-2031)

Figure 41. Latin America Peptide Therapeutics Revenue Market Share by Type (2020-2025)

Figure 42. Latin America Peptide Therapeutics Revenue Market Share by Application (2020-2025)

Figure 43. Middle East and Africa Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 44. Middle East and Africa Peptide Therapeutics Revenue Market Share by Country (2020-2031)

Figure 45. Middle East and Africa Peptide Therapeutics Revenue Market Share by Type (2020-2025)

Figure 46. Middle East and Africa Peptide Therapeutics Revenue Market Share by Application (2020-2025)

Figure 47. Peptide Therapeutics Supply Chain (Upstream and Downstream Market)

Figure 48. Global Production Market Share of Peptide Therapeutics Raw Materials by Region in 2024

Figure 49. Peptide Therapeutics Distribution Channels

Figure 50. Global Peptide Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 51. Global Peptide Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed